AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
February 03, 2021 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
Global COVID-19 Diagnostics Market Size Worth USD 11.40 Billion at 7.9% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
January 19, 2021 06:05 ET
|
Fortune Business Insights
Pune, India, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period....
COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
October 26, 2020 07:34 ET
|
Fortune Business Insights
Pune, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. ...
COVID-19 Diagnostics Market to Hit USD 11.40 Billion by 2027; Growing Urgency for Efficient Testing of Symptomatic COVID Patients to Boost the Market: Fortune Business Insights™
July 17, 2020 12:13 ET
|
Fortune Business Insights
Pune, July 17, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period....
Gibson Diagnostic Labs Provides Recommendations on How to Safely Reopen Practices
July 07, 2020 11:45 ET
|
Gibson Diagnostic Labs
IRVING, TX, July 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Keeping patients and staff safe is always our priority here at Gibson Diagnostic Labs. Now, it is even more important than ever. ...
Global WholeHealth Partners Submits “Made in the USA” COVID-19 Diagnostic Test EUA Application # EUA200181
June 24, 2020 08:44 ET
|
Global WholeHealth Partners Corp.
Global WholeHealth Partners Corp. (OTC MKTS: GWHP) announced today that an application for Emergency Use Authorization (EUA) is under review at the U.S. Food and Drug Administration (FDA) for its...
COVID-19 Diagnostic Kits and Therapy Market to Reach $13.9 Billion by 2025- Exclusive Report by Meticulous Research®
June 19, 2020 12:58 ET
|
Meticulous Market Research Pvt. Ltd.
London, June 19, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based,...